证券代码：301305 证券简称：朗坤环境 公告编号：2023-052 深圳市朗坤环境集团股份有限公司 2023年第四次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 特别提示: 1、本次股东大会无变更、否决提案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开情况 1、现场会议召开时间：2023年11月13日（星期一）下午15:00 2、网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2023 年 11 月 13 日 的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统进行网络投票的具体时间为：2023 年 11 月 13 日 9:15-15:00 期间的任意时间。 3、会议召开地点：深圳市龙岗区坪地街道高桥社区坪桥路 2 号朗坤科技园公 司会议室 4、会议的召开方式：现场表决与网络投票相结合的方式 本次会议采取现场表决和网络投票相结合的方式，出席本次会议的股东或股东 代理人共计19名，代表有表决权股份数101,559,0 ...

证券代码：301305 证券简称：朗坤环境 公告编号：2023-051 深圳市朗坤环境集团股份有限公司 关于全资子公司北京华融生物科技有限公司与北京市通州 区张家湾镇人民政府签署《监管协议》的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、对外投资概述 四、风险提示 项目在建设过程中及建成后可能面临宏观经济、行业环境、市场变化等因素 的影响，存在一定的市场风险、经营风险、管理风险等。公司将密切关注项目的 进展及后续运营，积极防范和应对生物科技创新中心可能面临的各种风险，并严 格按照相关法律、法规及规范性文件的要求及时履行信息披露义务。敬请广大投 资者理性投资，注意投资风险。 五、备查文件 1、《监管协议》。 特此公告。 深圳市朗坤环境集团股份有限公司董事会 深圳市朗坤环境集团股份有限公司（以下简称"公司"）于 2023 年 10 月 25 日召开的第三届董事会第十二次会议审议通过了《关于全资子公司北京华融生物 科技有限公司与北京市通州区张家湾镇人民政府签署<监管协议>的议案》，公司 下属全资子公司北京华融生物科技有限公司（以下简称"华融生物"） ...

Financial Performance - The company reported a significant increase in revenue, achieving a total of RMB 1.2 billion for the first half of 2023, representing a year-on-year growth of 25%[19]. - The company’s operating revenue for the current reporting period is ¥791,813,044.08, a decrease of 14.94% compared to the same period last year[26]. - The net profit attributable to shareholders of the listed company is ¥96,610,884.91, down 28.10% year-on-year[26]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is ¥92,069,074.98, a decline of 28.31% compared to the previous year[26]. - The company reported a gross profit margin of 35% for the first half of 2023, an increase from 30% in the same period last year[19]. - The company’s total operating revenue for the first half of 2023 was ¥791,813,044.08, a decrease of 15% compared to ¥930,915,858.02 in the same period of 2022[191]. - The total profit for the first half of 2023 was ¥103,838,417.48, down from ¥146,723,264.24 in the same period of 2022[193]. - The company experienced a credit impairment loss of ¥6,431,056.49, compared to a loss of ¥4,510,317.01 in the previous year, reflecting a worsening in credit quality[193]. Cash Flow and Investments - The net cash flow from operating activities is ¥66,782,350.20, representing a significant decrease of 54.25% from the same period last year[26]. - The net cash flow from investing activities decreased by 56.34% to -¥127,606,389.88, mainly due to fewer ongoing projects compared to the previous year[60]. - The net cash flow from financing activities increased significantly by 1,649.58% to ¥1,330,866,581.73, primarily due to funds raised from a public offering[60]. - The net increase in cash and cash equivalents was ¥1,270,048,013.56, a 1,908.46% increase compared to the previous year, driven by higher cash inflows from financing activities[60]. - The company received CNY 1,453,122,118.24 from investment absorption, indicating strong capital inflow[199]. Market Expansion and Strategic Initiatives - The company is focused on expanding its market presence through strategic partnerships and acquisitions[15]. - The company is actively pursuing market expansion, with plans to enter three new provinces by the end of 2023, aiming for a 30% increase in market share[19]. - The company has completed two strategic acquisitions in the waste management sector, which are projected to contribute an additional RMB 300 million in revenue annually[19]. - The company is actively expanding into the synthetic biology manufacturing sector, focusing on producing biodegradable materials such as PHAs and HMOs[35]. - The company is exploring opportunities in renewable energy technologies to diversify its portfolio[15]. Research and Development - New product development and technological advancements are prioritized to enhance service offerings and operational efficiency[15]. - The company is investing in R&D for advanced waste treatment technologies, with an allocated budget of RMB 50 million for 2023[17]. - Research and development investment was ¥20.34 million, down 33.25% from ¥30.48 million in the previous year, as most R&D projects were in earlier stages[59]. - The company has developed core technologies in organic waste treatment, holding 169 patents, including 13 invention patents and 156 utility model patents[50]. Environmental Responsibility - The report emphasizes the commitment to environmental responsibility and sustainable practices in its operations[15]. - The company is actively involved in several waste management and recycling projects across various regions[15]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[113]. - The company adheres to multiple environmental standards, including the "Standard for Pollution Control of Domestic Waste Incineration" (GB18485-2014)[113]. - The company has implemented strict adherence to environmental regulations, ensuring compliance with various pollution discharge standards[116]. Shareholder Engagement and Governance - The company plans to distribute a cash dividend of 2 RMB per 10 shares to all shareholders, based on a total of 243,570,700 shares[5]. - The management team is dedicated to maintaining transparency and accountability in financial reporting[5]. - The company held a temporary shareholders' meeting on March 23, 2023, with 100% investor participation to discuss various proposals[106]. - The annual shareholders' meeting on June 28, 2023, had a participation rate of 53.66% and addressed multiple financial and operational proposals[2023]. - The company has maintained compliance with corporate governance standards as per relevant laws and regulations, ensuring a sound governance structure[125]. Risks and Challenges - The company is facing risks related to the expiration of BOT project operating rights and is taking measures to ensure continued operation and renewal[93]. - The company is facing safety risks due to the complexity and scale of its projects, which may lead to accidents or management oversights[96]. - Changes in tax policies could impact profitability, particularly if VAT rebates for waste-to-energy projects are reduced or eliminated[97]. - The company is investing in synthetic biology technology R&D, with potential risks if market trends or customer needs are misjudged[100]. - Accounts receivable are increasing as the company expands, posing risks if clients' creditworthiness declines, potentially affecting cash flow[101].

Financial Performance - The company's operating revenue for Q3 2023 was CNY 489,962,402.27, representing a 2.73% increase year-over-year, while the year-to-date revenue decreased by 8.95% to CNY 1,281,775,446.35[5] - Net profit attributable to shareholders for Q3 2023 was CNY 52,510,389.94, down 40.27% year-over-year, and year-to-date net profit decreased by 32.92% to CNY 149,121,274.85[5] - The basic and diluted earnings per share for Q3 2023 were both CNY 0.22, reflecting a 54.17% decline compared to the same period last year[5] - The total profit for Q3 2023 was approximately ¥158.69 million, a decrease from ¥240.34 million in the same period last year, representing a decline of about 34%[23] - The net profit attributable to shareholders of the parent company was approximately ¥149.12 million, down from ¥222.29 million year-on-year, reflecting a decrease of around 33%[23] - Operating cash flow for the period was approximately ¥116.95 million, significantly lower than ¥277.94 million in the previous year, indicating a decline of about 58%[24] - The basic and diluted earnings per share for Q3 2023 were both ¥0.71, down from ¥1.22 in the same period last year, reflecting a decrease of about 42%[23] Assets and Liabilities - The total assets as of September 30, 2023, were CNY 5,853,074,489.33, an increase of 31.25% from the end of the previous year[5] - Total assets increased to CNY 5,853,074,489.33 as of September 30, 2023, up from CNY 4,459,330,126.06 at the beginning of the year, representing a growth of approximately 31.2%[19] - Current assets totaled CNY 2,513,943,071.36, a significant increase from CNY 1,103,100,841.57, reflecting a growth of about 128.5%[19] - Total liabilities decreased to CNY 2,380,367,102.73 from CNY 2,519,951,616.16, indicating a reduction of about 5.5%[19] - Long-term borrowings decreased to CNY 1,729,078,199.96 from CNY 1,861,755,900.00, a decline of approximately 7.1%[19] Cash Flow - The company reported a 7104.81% increase in cash flow from financing activities, totaling CNY 1,203,605,280.86, primarily due to funds raised from a public offering[9] - The company’s cash flow from operating activities for the first nine months of 2023 was CNY 116,951,385.73, a significant decrease of 57.92% compared to the same period in 2022[9] - Cash and cash equivalents increased to CNY 1,534,553,410.27 from CNY 475,816,795.95, marking a growth of about 222.5%[19] - The company reported cash inflows from operating activities of approximately ¥1.24 billion, down from ¥1.32 billion year-on-year, a decrease of about 6%[24] - Total cash outflows from investment activities were approximately ¥1.20 billion, compared to ¥1.05 billion in the previous year, indicating an increase of about 14%[25] - The net cash flow from financing activities was approximately ¥1.20 billion, a significant increase from ¥16.71 million in the same period last year[25] Accounts and Inventory - Accounts receivable increased by 53.64% to CNY 380,649,416.15, attributed to delayed settlements from sales and extended payment terms for certain projects[9] - Accounts receivable rose to CNY 380,649,416.15 from CNY 247,749,039.53, an increase of approximately 53.5%[19] - Inventory rose by 44.78% to CNY 99,952,826.95, driven by increased orders for biodiesel[9] - Inventory increased to CNY 99,952,826.95 from CNY 69,036,916.06, reflecting a growth of about 44.7%[19] Shareholder Information - The company reported a total of 182,678,000 restricted shares at the end of the period, with no shares released from restrictions during the quarter[12] - The largest shareholder, Shenzhen Jianyin Wealth Investment Holdings Co., held 28,800,000 shares, representing a significant portion of the total shares[12] - The company has a total of 56,153,600 shares under lock-up until November 25, 2026, indicating a long-term commitment from major shareholders[14] - The company announced no changes in the number of restricted shares for key shareholders during the quarter, maintaining stability in ownership structure[14] - The company continues to engage in significant shareholder relationships, with multiple shareholders holding substantial stakes[12] Operational Activities - The company has ongoing projects and contracts signed as of July 10, 2023, indicating active engagement in its operational activities[15] - The company plans to supplement its working capital with surplus funds from completed fundraising projects, enhancing liquidity[15] - The company is in the process of revising its business scope and updating its articles of association, reflecting strategic adjustments[15] - The company has retained its accounting firm for the fiscal year 2023, ensuring continuity in financial oversight[15] - The company has not reported any changes in its preferred stockholder structure, maintaining focus on common equity[12] Expenses - The company experienced a 92.17% increase in selling expenses, totaling CNY 16,448,635.87, due to expanded market development efforts outside Guangdong[9] - Total operating costs decreased to CNY 1,156,520,031.00 from CNY 1,211,856,705.02, a reduction of about 4.6%[22]

一、召开会议的基本情况 证券代码：301305 证券简称：朗坤环境 公告编号：2023-049 深圳市朗坤环境集团股份有限公司 关于召开2023年第四次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 根据《公司法》和《深圳市朗坤环境集团股份有限公司章程》的有关规定， 经深圳市朗坤环境集团股份有限公司（以下简称"公司"）第三届董事会第十二 次会议审议通过《关于提请召开 2023 年度第四次临时股东大会的议案》，决定 于 2023 年 11 月 13 日（星期一）15:00 召开 2023 年第四次临时股东大会，现将 会议有关事项通知如下： 1、股东大会届次：2023 年第四次临时股东大会 2、会议召集人：公司董事会 3、会议召开的合法性、合规性：本次股东大会的召开符合有关法律、法规和《公 司章程》的有关规定。 4、会议召开的日期、时间： （1）现场会议召开时间：2023 年 11 月 13 日 15:00 （2）网络投票时间：通过深圳证券交易所（以下简称"深交所"）交易系统进 行网络投票的具体时间为：2023 年 11 月 13 日的交易时 ...

深圳市朗坤环境集团股份有限公司 第三届监事会第四次会议决议 深圳市朗坤环境集团股份有限公司(以下简称"公司")第三届监事会第四次会 议于 2023年 10 月 25 日在公司会议室召开,公司全体监事出席了会议,符合国家有 关法律、法规及公司章程的规定。会议由监事会主席源晓燕主持,经全体监事表决, 形成决议如下: (一)经记名投票表决,以 3 票赞成,0 票反对,0 票弃权,审议并通过《关于 <2023 年第三季度报告>的议案》; 深圳市朗坤 口 士不 25 日 （本页无正文,为《深圳市朗坤环境集团股份有限公司第三届监事会第 四次会议决议》签署页) 监事 李立: (二)经记名投票表决,以3票赞成,0票反对,0票奔权,审议并通过《关于 公司申请银行授信及接受关联方担保的议案》; (三)经记名投票表决,以 3 票赞成,0 票反对,0 票弃权,审议并通过《关于 公司为控股子公司提供担保及接受关联方担保的议案》 特此决议! 【以下无正文】 （本页无正文，为《深圳市朗坤环境集团股份有限公司第三届监事会第 四次会议决议》签署页) 监事 源晓燕: 深圳市朗坤环 司 I （本页无正文,为《深圳市朗坤环境集团股份有限公司第三届监 ...

证券代码：301305 证券简称：朗坤环境 公告编号：2023-042 深圳市朗坤环境集团股份有限公司 第三届董事会第十二次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 深圳市朗坤环境集团股份有限公司（以下简称"公司"或"朗坤环境"）第 三届董事会第十二次会议通知于 2023 年 10 月 21 日以电子邮件方式发出，会议 于 2023 年 10 月 25 日在公司会议室以现场结合通讯的方式召开。会议由董事长 陈建湘先生主持，应到董事 7 人，实到董事 7 人。公司监事及高级管理人员列席 了会议。会议的召集、召开和表决程序符合《公司法》等法律、法规和《公司章 程》的有关规定。 二、董事会会议审议情况 公司出具的《2023 年第三季度报告》符合法律、行政法规、中国证监会和 深圳证券交易所的规定，报告内容真实、准确、完整的反映了公司 2023 年前三 季度经营的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 《2023 年第三季度报告》全文详见披露于巨潮资讯网（www.cninfo.com.cn） 的相关公告。 ...

证券代码：301305 证券简称：朗坤环境 公告编号：2023-047 公司于 2023 年 10 月 25 日召开的第三届董事会第十二次会议审议通过了 《关于全资子公司北京华融生物科技有限公司与北京市通州区张家湾镇人民政 府签署<监管协议>的议案》，并授权公司管理层负责办理本次投资建设的相关事 宜。根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》及《公司章程》的有关规定， 本次投资事项在董事会审议权限范围内，无需提交股东大会审议。 （三）不构成关联交易 本次对外投资不构成关联交易，亦不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 深圳市朗坤环境集团股份有限公司 关于全资子公司北京华融生物科技有限公司与北京市通州 一、对外投资概述 （一）基本情况 深圳市朗坤环境集团股份有限公司（以下简称"公司"）下属全资子公司北 京华融生物科技有限公司（以下简称"华融生物"）拟与北京市通州区张家湾镇 人民政府签署《监管协议》，计划使用自有资金或其他自筹资金（具体以实际投 资为准），在张家湾镇镇域内取得土地投资建设北京智慧生物科技创新中心建设 项 ...

深圳市朗坤环境集团股份有限公司 第三届董事会第十二次会议决议 2023年 10月 21日,深圳市朗坤环境集团股份有限公司(以下简称"公司")董 事会以邮件、电话等方式向公司全体董事、监事和高级管理人员发出关于召开公司 第三届董事会第十二次会议〈以下简称"本次会议"）的通知;2023年 10 月 25 日 15时,本次会议以现场+腾讯视频会议的形式召开,由公司董事长陈建湘先生主持。 本次会议应参与董事 7人,实际参与董事 7人,公司监事、高级管理人员列席了本 次会议,符合《中华人民共和国公司法》和《深圳市朗坤环境集团股份有限公司章 程》(以下简称"《公司章程》"）的有关规定。经与会董事审议表决,本次会议通过 了以下议案: (一)会议以_7_票同意、_0_票反对、_ 0_票弃权的表决结果审议通过 了《关于<2023年第三季度报告>的议案》。 (二)会议以 6 票同意、 0 票反对、 0 票弃权的表决结果审议通过 了《关于公司申请银行授信及接受关联方担保的议案》。 关联董事陈建湘回避了对该项议案的表决。 (三)会议以 6 票同意、 0 票反对、 0 票弃权的表决结果审议通过 了《关于公司为控股子公司提供担保及接受关 ...

一、申请授信及接受关联方担保情况 为保证公司日常运营资金需求，公司拟向招商银行股份有限公司深圳分行申 请总金额不超过人民币 10,000 万元的综合授信额度，业务品种包括不限于流动 资金贷款、非融资性保函（不超过 3 年）、银行承兑汇票、信用证等，授信额度 有效期不超过 3 年（具体业务期限以签订的相关合同约定为准），担保方式包括 但不限于实际控制人陈建湘提供无偿连带责任担保（具体担保内容及担保责任以 担保合同约定为准），公司无需向陈建湘提供反担保。 二、决策及审批程序 公司于 2023 年 10 月 25 日召开第三届董事会第十二次会议和第三届监事会 第四次会议，审议通过了《关于公司申请银行授信及接受关联方担保的议案》， 上述议案的授权有效期为股东大会审议通过之日起 1 年，公司董事会提请股东 大会授权公司财务管理中心根据公司实际经营情况的需要，在上述额度范围内， 全权办理公司向金融机构申请授信及接受担保相关的具体事项。 证券代码：301305 证券简称：朗坤环境 公告编号：2023-045 深圳市朗坤环境集团股份有限公司 关于公司申请银行授信及接受关联方担保的公告 本公司及董事会全体成员保证信息披露的内容 ...